ONGAVIA

Dead / Abandoned — Abandoned — no statement of use filed (as of 12 Nov 2018)

What this means for you

This application is over — abandoned 12 Nov 2018. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
86944227
Mark type
Stylized text
Filed
17 Mar 2016
Published for opposition
16 Aug 2016
Abandoned
12 Nov 2018
Attorney of record
Matthew O. Brady

Goods and services

  • Class 005 — Pharmaceuticals: Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceuticals and medicines affecting urogenital organs; Pharmaceuticals and medicines affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceuticals used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma and decongestant formulations; sterile ointments; ocular wetting solutions, artificial tears and formulations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body

Owner

Prosecution history

  • 13 Dec 2018 — UNDELIVERABLE MAIL - NO ACTION TAKEN
  • 13 Nov 2018 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
  • 12 Nov 2018 — ABANDONMENT - NO USE STATEMENT FILED
  • 12 Jun 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 11 Jun 2018 — SOU EXTENSION 3 GRANTED
  • 11 Apr 2018 — SOU EXTENSION 3 FILED
  • 11 Jun 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 24 May 2018 — UNDELIVERABLE MAIL - NO ACTION TAKEN
  • 15 May 2018 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 16 May 2018 — ASSIGNED TO EXAMINER
  • 15 May 2018 — NOTICE OF REVIVAL - E-MAILED
  • 15 May 2018 — SOU EXTENSION RECEIVED WITH TEAS PETITION
  • 15 May 2018 — PETITION TO REVIVE-GRANTED
  • 15 May 2018 — TEAS PETITION TO REVIVE RECEIVED
  • 14 May 2018 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED

View this trademark record on Marksy